International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
暂无分享,去创建一个
Marc Parmentier | Charles N. Serhan | Claes Dahlgren | Philip M. Murphy | Richard D. Ye | M. Parmentier | Ji Ming Wang | R. Ye | C. Serhan | P. Murphy | C. Dahlgren | C. Gerard | Craig Gerard | F. Boulay | François Boulay
[1] Ravi S. Misra,et al. Identification of an alternative Gαq-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes , 2007, The Journal of experimental medicine.
[2] V. Ferrans,et al. Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] C. Clish,et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.
[4] C. Turck,et al. Tethered Ligand Library for Discovery of Peptide Agonists (*) , 1995, The Journal of Biological Chemistry.
[5] S. Marullo,et al. Annexin 1 Binds to U937 Monocytic Cells and Inhibits Their Adhesion to Microvascular Endothelium: Involvement of the α4β1 Integrin1 , 2000, The Journal of Immunology.
[6] E. Prossnitz,et al. Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells. , 1993, Journal of immunology.
[7] W. Shen,et al. Amyloid β42 Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1 , 2001, The Journal of Neuroscience.
[8] M. Baggiolini,et al. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. , 1992, Journal of immunology.
[9] R. Lefkowitz,et al. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Flynn,et al. Aggregation, chemotaxis, and chemiluminescence of canine granulocytes , 1983, Inflammation.
[11] F. Boulay,et al. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. , 1994, The Journal of biological chemistry.
[12] H. Showell,et al. Specific binding of synthetic chemotactic peptides to rabbit peritoneal neutrophils: effects on dissociability of bound peptide, receptor activity and subsequent biologic responsiveness (deactivation). , 1980, Molecular immunology.
[13] A. Khlebnikov,et al. High-Throughput Screening for Small-Molecule Activators of Neutrophils: Identification of Novel N-Formyl Peptide Receptor Agonists , 2007, Molecular Pharmacology.
[14] B. Seligmann,et al. Fluorescence analysis of the size of a binding pocket of a peptide receptor at natural abundance. , 1990, Biochemistry.
[15] A. Mócsai,et al. Kinase Pathways in Chemoattractant-Induced Degranulation of Neutrophils: The Role of p38 Mitogen-Activated Protein Kinase Activated by Src Family Kinases1 , 2000, The Journal of Immunology.
[16] C. Serhan. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.
[17] Brian K. Kobilka,et al. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin , 1986, Nature.
[18] A. Gilman,et al. Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin , 1984, Cell.
[19] K. Okkenhaug,et al. P-Rex1 Regulates Neutrophil Function , 2005, Current Biology.
[20] Ji Ming Wang,et al. Pleiotropic roles of formyl peptide receptors. , 2001, Cytokine & growth factor reviews.
[21] L. Boxer,et al. Differences in polymorphonuclear leukocyte aggregating responses among several species in response to chemotactic stimulation. , 1980, The Journal of laboratory and clinical medicine.
[22] R. Snyderman,et al. Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants. , 1987, Journal of immunology.
[23] J W Sedat,et al. Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis. , 1999, Molecular biology of the cell.
[24] Jilly F. Evans,et al. International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors , 2003, Pharmacological Reviews.
[25] Valérie Capra,et al. The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State , 2007, Molecular Pharmacology.
[26] S. Marullo,et al. Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. , 2000, Journal of immunology.
[27] E. Dratz,et al. Extensive contact between Gi2 and N-formyl peptide receptor of human neutrophils: mapping of binding sites using receptor-mimetic peptides. , 1995, Biochemistry.
[28] J. Köhl,et al. Gα‐16 complements the signal transduction cascade of chemotactic receptors for complement factor C5a (C5a‐R) and N‐formylated peptides (fMLF‐R) in Xenopus laevis oocytes: Gα‐16 couples to chemotactic receptors in Xenopus oocytes , 1995, FEBS letters.
[29] S. Ryu,et al. Identification of the Peptides That Stimulate the Phosphoinositide Hydrolysis in Lymphocyte Cell Lines from Peptide Libraries (*) , 1996, The Journal of Biological Chemistry.
[30] R. Lefkowitz,et al. beta-arrestins: traffic cops of cell signaling. , 2004, Current opinion in cell biology.
[31] P. Murphy,et al. Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils. , 2000, Biochemical and biophysical research communications.
[32] M. Perretti,et al. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. , 2006, Blood.
[33] P. Cuatrecasas,et al. A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Parmentier,et al. F2L, a Peptide Derived from Heme-Binding Protein, Chemoattracts Mouse Neutrophils by Specifically Activating Fpr2, the Low-Affinity N-Formylpeptide Receptor1 , 2007, The Journal of Immunology.
[35] A. Toporik,et al. A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects , 2009, Journal of Pharmacology and Experimental Therapeutics.
[36] Philip M. Murphy,et al. Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106–126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 11 2 , 2001, The Journal of Immunology.
[37] K. Jakobs,et al. Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells. , 1989, The Journal of biological chemistry.
[38] J. Savill. Apoptosis in resolution of inflammation , 1997, Journal of leukocyte biology.
[39] Henry R. Bourne,et al. Receptors induce chemotaxis by releasing the βγ subunit of Gi, not by activating Gq or Gs , 1997 .
[40] P. Hawkins,et al. P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. , 2002, Cell.
[41] R. Snyderman,et al. N-Formylmethionyl peptide receptors on equine leukocytes initiate secretion but not chemotaxis. , 1980, Science.
[42] Sheng-hua Wu,et al. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells. , 2005, Kidney international.
[43] E. Pamer,et al. Infection with Listeria monocytogenes impairs sialic acid addition to host cell glycoproteins , 1994, The Journal of experimental medicine.
[44] K. Klotz,et al. Reconstitution of a physical complex between the N-formyl chemotactic peptide receptor and G protein. Inhibition by pertussis toxin-catalyzed ADP ribosylation. , 1992, The Journal of biological chemistry.
[45] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[46] Richard A. Firtel,et al. Spatial and Temporal Regulation of 3-Phosphoinositides by PI 3-Kinase and PTEN Mediates Chemotaxis , 2002, Cell.
[47] G. Bokoch,et al. Mastoparan interacts with the carboxyl terminus of the alpha subunit of Gi. , 1990, The Journal of biological chemistry.
[48] P. Cuatrecasas,et al. Covalent affinity labeling of the formyl peptide chemotactic receptor. , 1980, The Journal of biological chemistry.
[49] Marc Parmentier,et al. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. , 2006, Cytokine & growth factor reviews.
[50] V. Ferrans,et al. The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. , 2001, Journal of immunology.
[51] C. Toniolo,et al. N alpha-formylated and tert-butyloxycarbonylated Phe-(Leu-Phe)n and (Leu-Phe)n peptides as agonists and antagonists of the chemotactic formylpeptide receptor of the rabbit peritoneal neutrophil. , 1990, Biochimica et biophysica acta.
[52] E. Grazzini,et al. A truncated form of CKβ8‐1 is a potent agonist for human formyl peptide‐receptor‐like 1 receptor , 2004, British journal of pharmacology.
[53] B. Heit,et al. PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils , 2008, Nature Immunology.
[54] T. Kohout,et al. beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. Ye,et al. Normal Cell Surface Expression and Selective Loss of Functions Resulting from Phe110 to Ser and Cys126 to Trp Substitutions in the Formyl Peptide Receptor , 2004, Immunological investigations.
[56] R. Liskamp,et al. N-Terminal Residues of the Chemotaxis Inhibitory Protein of Staphylococcus aureus Are Essential for Blocking Formylated Peptide Receptor but Not C5a Receptor , 2004, The Journal of Immunology.
[57] Caiying Guo,et al. P-Rex1 Is a Primary Rac2 Guanine Nucleotide Exchange Factor in Mouse Neutrophils , 2005, Current Biology.
[58] The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. , 2006, Biochemical pharmacology.
[59] Sophie Barral,et al. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling. , 2007, Cellular signalling.
[60] K. Hartshorn,et al. Priming of human neutrophils with N-formyl-methionyl-leucyl-phenylalanine by a calcium-independent, pertussis toxin-insensitive pathway. , 1989, Blood.
[61] J. Wang,et al. Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors , 2000, Inflammation Research.
[62] E. Kunkel,et al. Integrating Conflicting Chemotactic Signals , 1999, The Journal of cell biology.
[63] G. Bokoch,et al. Binding of Low Affinity N-formyl Peptide Receptors to G Protein , 1995, The Journal of Biological Chemistry.
[64] S. Lockett,et al. Activation of Toll-like Receptor 2 on Microglia Promotes Cell Uptake of Alzheimer Disease-associated Amyloid β Peptide* , 2006, Journal of Biological Chemistry.
[65] H. Bourne,et al. Gαi Is Not Required for Chemotaxis Mediated by Gi-coupled Receptors* , 1999, The Journal of Biological Chemistry.
[66] Y. Yamamoto,et al. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils. , 1997, Biochemical pharmacology.
[67] R. Arnold,et al. Neutrophil function in localized juvenile periodontitis. Phagocytosis, superoxide production and specific granule release. , 1986, Journal of periodontology.
[68] W. Gong,et al. Identification of functional domains in the formyl peptide receptor‐like 1 for agonist‐induced cell chemotaxis , 2005, The FEBS journal.
[69] E. Pamer,et al. H-2M3 presents a listeria monocytogenes peptide to cytotoxic T lymphocytes , 1992, Cell.
[70] C. Smith,et al. Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. , 1992, The Journal of clinical investigation.
[71] M. Gougerot-Pocidalo,et al. The Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway Is Involved in formyl-Methionyl-Leucyl-Phenylalanine-Induced p47phox Phosphorylation in Human Neutrophils1 , 2000, The Journal of Immunology.
[72] P. Murphy,et al. Amyloid-β Induces Chemotaxis and Oxidant Stress by Acting at Formylpeptide Receptor 2, a G Protein-coupled Receptor Expressed in Phagocytes and Brain* , 2001, The Journal of Biological Chemistry.
[73] James J. Campbell,et al. Multistep Navigation and the Combinatorial Control of Leukocyte Chemotaxis , 1997, The Journal of cell biology.
[74] P. Hargrave,et al. Three cytoplasmic loops of rhodopsin interact with transducin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[75] P. Ward,et al. Molecular and Cellular Basis of Inflammation , 1999, Current Inflammation Research.
[76] J S Mills,et al. Characterization of the Binding Site on the Formyl Peptide Receptor Using Three Receptor Mutants and Analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu* , 2000, The Journal of Biological Chemistry.
[77] R. Ye,et al. Pharmacological Characterization of a Novel Nonpeptide Antagonist for Formyl Peptide Receptor-Like 1 , 2007, Molecular Pharmacology.
[78] R. Ye,et al. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. , 2003, Blood.
[79] L. Sklar,et al. Ligand/receptor internalization: a kinetic, flow cytometric analysis of the internalization of N-formyl peptides by human neutrophils. , 1983, Cytometry.
[80] W. Gong,et al. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. , 1999, Journal of immunology.
[81] R. Buerli. Potent hFPRL1 (ALXR) Agonists as Potential Antiinflammatory Agents. , 2006 .
[82] R. Eddy,et al. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. , 1992, Genomics.
[83] W. Gong,et al. Synthetic peptide MMK‐1 is a highly specific chemotactic agonist for leukocyte FPRL1 , 2001, Journal of leukocyte biology.
[84] E. Prossnitz,et al. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. , 1992, Biochemical and biophysical research communications.
[85] L. Taylor,et al. The interleukin-8 receptor is encoded by a neutrophil-specific cDNA clone, F3R. , 1991, The Journal of biological chemistry.
[86] S. Rosenzweig,et al. Asparagine-linked oligosaccharides on formyl peptide chemotactic receptors of human phagocytic cells. , 1985, The Journal of biological chemistry.
[87] C. Wennerås,et al. Cyclosporin H, Boc-MLF and Boc-FLFLF are Antagonists that Preferentially Inhibit Activity Triggered Through the Formyl Peptide Receptor , 2007, Inflammation.
[88] P. Ward,et al. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. , 1975, Journal of immunology.
[89] D. Dormann,et al. Visualizing PI3 Kinase-Mediated Cell-Cell Signaling during Dictyostelium Development , 2002, Current Biology.
[90] R. Snyderman,et al. Chemoattractant Receptor Cross-desensitization* , 1999, The Journal of Biological Chemistry.
[91] R. Snyderman,et al. Functional high efficiency expression of cloned leucocyte chemoattractant receptor cDNAs , 1992, FEBS letters.
[92] F. D. de Beer,et al. Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake* , 2005, Journal of Biological Chemistry.
[93] R. Kettritz,et al. Neutrophil superoxide release is required for spontaneous and FMLP-mediated but not for TNF alpha-mediated apoptosis. , 1997, Journal of the American Society of Nephrology : JASN.
[94] M. Yaffe,et al. Distinct Ligand-dependent Roles for p38 MAPK in Priming and Activation of the Neutrophil NADPH Oxidase* , 2004, Journal of Biological Chemistry.
[95] A. Arcaro,et al. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. , 1993, The Biochemical journal.
[96] A. Jesaitis,et al. Fluoresceinated chemotactic peptide and high-affinity antifluorescein antibody as a probe of the temporal characteristics of neutrophil stimulation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[97] M. Simon,et al. G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. , 1995, The Journal of biological chemistry.
[98] S. Zigmond,et al. ABILITY OF POLYMORPHONUCLEAR LEUKOCYTES TO ORIENT IN GRADIENTS OF CHEMOTACTIC FACTORS , 2003 .
[99] M. Parmentier,et al. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2 , 2005, The Journal of experimental medicine.
[100] E. Prossnitz,et al. Differential Phosphorylation Paradigms Dictate Desensitization and Internalization of the N-Formyl Peptide Receptor* , 1999, The Journal of Biological Chemistry.
[101] M. Mishina,et al. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor , 1986, Nature.
[102] Melvin I. Simon,et al. Diversity of G proteins in signal transduction , 1991, Science.
[103] M. Camps,et al. Isozyme-selective stimulation of phospholipase C-β2 by G protein βγ-subunits , 1992, Nature.
[104] Robert J. Lefkowitz,et al. beta-arrestins: traffic cops of cell signaling. , 2004, Current opinion in cell biology.
[105] R. Medzhitov,et al. Innate immune recognition: mechanisms and pathways , 2000, Immunological reviews.
[106] M. Simon,et al. Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C (*) , 1995, The Journal of Biological Chemistry.
[107] C. Svensson,et al. Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing , 2007, The Journal of experimental medicine.
[108] J. Benovic,et al. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.
[109] N. Oppenheimer,et al. Chemotaxis and Calcium Responses of Phagocytes to Formyl Peptide Receptor Ligands Is Differentially Regulated by Cyclic ADP Ribose1 , 2004, The Journal of Immunology.
[110] L. M. Sam,et al. Diacylglycerols Modulate Human Polymorphonuclear Neutrophil Responsiveness: Effects on Intracellular Calcium Mobilization, Granule Exocytosis, and Superoxide Anion Production , 1988, Journal of leukocyte biology.
[111] Dianqing Wu,et al. Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction , 2000 .
[112] H. Morton,et al. Staphylococcus aureus , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[113] P. Ward,et al. Bacterial factors chemotactic for polymorphonuclear leukocytes. , 1968, The American journal of pathology.
[114] P. Murphy,et al. Functional expression of the human formyl peptide receptor in Xenopus oocytes requires a complementary human factor. , 1991, The Journal of biological chemistry.
[115] K. Matsushima,et al. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. , 1993, International immunology.
[116] J. Bylund,et al. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7‐sensitive pathway independent of formyl peptide receptor‐like 1 , 2008, Journal of leukocyte biology.
[117] John I. Gallin,et al. Inflammation: Basic Principles and Clinical Correlates , 1992 .
[118] R. Snyderman,et al. Receptor class desensitization of leukocyte chemoattractant receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[119] H. Perez,et al. Signal Transduction by the Formyl Peptide Receptor , 1995, The Journal of Biological Chemistry.
[120] D. Gilroy,et al. 15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation , 2004, The Journal of experimental medicine.
[121] Adil I. Khan,et al. Lipopolysaccharide: A p38 MAPK‐Dependent Disrupter of Neutrophil Chemotaxis , 2005, Microcirculation.
[122] P. Janmey,et al. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide , 2004, BMC Cell Biology.
[123] Takao Shimizu,et al. The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo , 2006, Pharmacological Reviews.
[124] W. Gong,et al. Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[125] P. Murphy,et al. A high potency nonformylated peptide agonist for the phagocyte N- formylpeptide chemotactic receptor , 1994, The Journal of experimental medicine.
[126] K. Wenzel-Seifert,et al. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation. , 1991, Journal of immunology.
[127] W L Stanford,et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.
[128] D. Cimino,et al. Internalization of the human N-formyl peptide and C5a chemoattractant receptors occurs via clathrin-independent mechanisms. , 2001, Biochemistry.
[129] A. Kirk,et al. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. , 2005, Experimental hematology.
[130] C. Serhan,et al. Aspirin‐triggered lipoxin A4 and lipoxin A4 up‐regulate transcriptional corepressor NAB1 in human neutrophils , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[131] M. Perretti. The annexin 1 receptor(s): is the plot unravelling? , 2003, Trends in pharmacological sciences.
[132] P. Murphy,et al. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils. , 2002, Cellular immunology.
[133] A. Karlsson,et al. Lipopolysaccharide-Induced Granule Mobilization and Priming of the Neutrophil Response to Helicobacter pylori Peptide Hp(2-20), Which Activates Formyl Peptide Receptor-Like 1 , 2002, Infection and Immunity.
[134] P. Ward,et al. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors. , 1984, The American journal of pathology.
[135] A. Karlsson,et al. Phagocyte Activation by Trp–Lys–Tyr–Met–Val–Met, Acting through FPRL1/LXA4R, is not Affected by Lipoxin A4 , 2002, Scandinavian journal of immunology.
[136] W. Gong,et al. Humanin, a Newly Identified Neuroprotective Factor, Uses the G Protein-Coupled Formylpeptide Receptor-Like-1 as a Functional Receptor1 , 2004, The Journal of Immunology.
[137] Sheng-hua Wu,et al. Signal pathway involved in inhibition by lipoxin A4 of production of interleukins induced in endothelial cells by lipopolysaccharide , 2008, Inflammation Research.
[138] A. Fischman,et al. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues. , 1996, Biochemistry.
[139] P. Smiley,et al. Association of the N-formyl-Met-Leu-Phe receptor in human neutrophils with a GTP-binding protein sensitive to pertussis toxin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[140] E. Ogier-Denis,et al. Interleukin-8-induced Priming of Neutrophil Oxidative Burst Requires Sequential Recruitment of NADPH Oxidase Components into Lipid Rafts* , 2005, Journal of Biological Chemistry.
[141] M. Caron,et al. Role of acidic amino acids in peptide substrates of the beta-adrenergic receptor kinase and rhodopsin kinase. , 1991, Biochemistry.
[142] W. Gong,et al. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. , 1999, Blood.
[143] T. Takano,et al. Lipoxin A4 Stable Analogs Are Potent Mimetics That Stimulate Human Monocytes and THP-1 Cells via a G-protein-linked Lipoxin A4 Receptor* , 1997, The Journal of Biological Chemistry.
[144] Y. Izumi,et al. Functional polymorphisms of the FPR1 gene and aggressive periodontitis in Japanese. , 2007, Biochemical and biophysical research communications.
[145] A. Jesaitis,et al. Preparation and properties of an improved photoaffinity ligand for the N-formyl peptide receptor. , 1986, Biochimica et biophysica acta.
[146] R. Snyderman,et al. Cross-desensitization of Chemoattractant Receptors Occurs at Multiple Levels , 1995, The Journal of Biological Chemistry.
[147] K. Wenzel-Seifert,et al. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E. , 1993, Journal of immunology.
[148] K. Wenzel-Seifert,et al. Cyclosporin H Is a Potent and Selective Formyl Peptide Receptor Antagonist Comparison with Nt-Butoxycarbonyl-~-phenylalanyl-L-leucyl-L-phenylalanyl-1-leucyl-L-phenylalanine and Cyclosporins , 2001 .
[149] H. Korchak,et al. Stimulus response coupling in the human neutrophil. Differential requirements for receptor occupancy in neutrophil responses to a chemoattractant. , 1984, The Journal of biological chemistry.
[150] Ji Ming Wang,et al. Differential Regulation of Formyl Peptide Receptor-Like 1 Expression During the Differentiation of Monocytes to Dendritic Cells and Macrophages1 , 2001, The Journal of Immunology.
[151] F. Setién,et al. Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates , 2007, Immunogenetics.
[152] Silvano Sozzani,et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .
[153] J. El Benna,et al. Protein Kinase C ζ Phosphorylates a Subset of Selective Sites of the NADPH Oxidase Component p47phox and Participates in Formyl Peptide-Mediated Neutrophil Respiratory Burst , 2001, The Journal of Immunology.
[154] C. Serhan,et al. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. , 1993, The Journal of clinical investigation.
[155] R. Ye,et al. Human dendritic cells express functional formyl peptide receptor‐like‐2 (FPRL2) throughout maturation , 2002, Journal of leukocyte biology.
[156] J. Varga,et al. Opposing Regulation of Interleukin-8 and NF-kB Responses by Lipoxin A4 and Serum Amyloid a via the Common Lipoxin a Receptor , 2004, International journal of immunopathology and pharmacology.
[157] A. Karlsson,et al. The mechanism for activation of the neutrophil NADPH‐oxidase by the peptides formyl‐Met‐Leu‐Phe and Trp‐Lys‐Tyr‐Met‐Val‐Met differs from that for interleukin‐8 , 2004, Immunology.
[158] J. Mills. Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor , 2006, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[159] A. Karlsson,et al. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like‐1 , 2008, Journal of leukocyte biology.
[160] L. Sklar,et al. Inhibition of Chemoattractant N‐Formyl Peptide Receptor Trafficking by Active Arrestins , 2005, Traffic.
[161] E. Butcher,et al. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration , 1997, European journal of immunology.
[162] 서판길,et al. Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1 , 2006 .
[163] C. Serhan,et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[164] J. Kwak,et al. Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling1 , 2004, The Journal of Immunology.
[165] J. Lambeth,et al. The neutrophil NADPH oxidase. , 2002, Archives of biochemistry and biophysics.
[166] I. Fierro,et al. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. , 2005, American journal of physiology. Cell physiology.
[167] K. Wenzel-Seifert,et al. Defective Gi Protein Coupling in Two Formyl Peptide Receptor Mutants Associated with Localized Juvenile Periodontitis* , 2001, The Journal of Biological Chemistry.
[168] R. Traber,et al. Chemistry of the natural cyclosporin metabolites. , 1986, Progress in allergy.
[169] A. Day,et al. Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. , 1977, Biochemical and biophysical research communications.
[170] P. Murphy,et al. The Endogenous Opioid Spinorphin Blocks fMet-Leu-Phe-Induced Neutrophil Chemotaxis by Acting as a Specific Antagonist at the N-Formylpeptide Receptor Subtype FPR , 2001, The Journal of Immunology.
[171] T. Molski,et al. Activation of the neutrophil. , 1988, Progress in allergy.
[172] A. Sher,et al. Parasite-induced Lipoxin A4 Is an Endogenous Regulator of IL-12 Production and Immunopathology in Toxoplasma gondii Infection , 2002, The Journal of experimental medicine.
[173] H. Lodish,et al. Expression cloning of the murine erythropoietin receptor , 1989, Cell.
[174] A. Newton,et al. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1) , 1998, Current Biology.
[175] S. Lockett,et al. Identification of Neutrophil Granule Protein Cathepsin G as a Novel Chemotactic Agonist for the G Protein-Coupled Formyl Peptide Receptor 12 , 2004, The Journal of Immunology.
[176] R. Page,et al. Defective neutrophil chemotaxis in juvenile periodontitis , 1977, Infection and immunity.
[177] J. Penninger,et al. The Hemopoietic Rho/Rac Guanine Nucleotide Exchange Factor Vav1 Regulates N-Formyl-Methionyl-Leucyl-Phenylalanine-Activated Neutrophil Functions 1 , 2003, The Journal of Immunology.
[178] Anna Karlsson,et al. A Proinflammatory Peptide from Herpes Simplex Virus Type 2 Glycoprotein G Affects Neutrophil, Monocyte, and NK Cell Functions1 , 2005, The Journal of Immunology.
[179] Ji Ming Wang,et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[180] J. Broach,et al. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast , 1998, Nature Biotechnology.
[181] C. Dahlgren,et al. Subinhibitory Concentrations of the Deformylase Inhibitor Actinonin Increase Bacterial Release of Neutrophil-Activating Peptides: a New Approach to Antimicrobial Chemotherapy , 2003, Antimicrobial Agents and Chemotherapy.
[182] M. Simon,et al. Roles of phospholipase C beta2 in chemoattractant-elicited responses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[183] J. El-Benna. The Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway Is Involved in formyl-Methionyl-Leucyl-Phenylalanine-Induced p47 Phosphorylation in Human Neutrophils , 2000 .
[184] T C Hart,et al. Evaluation of human leukocyte N-formylpeptide receptor (FPR1) SNPs in aggressive periodontitis patients , 2003, Genes and Immunity.
[185] J. McClary,et al. Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. , 1992, Gene.
[186] S. Baek,et al. Serum Amyloid A Induces Contrary Immune Responses via Formyl Peptide Receptor-Like 1 in Human Monocytes , 2006, Molecular Pharmacology.
[187] R. Snyderman,et al. Stimulation of neutrophil oxidative metabolism by chemotactic peptides: influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate. , 1979, Blood.
[188] M. Tardif,et al. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells. , 1993, Journal of immunology.
[189] Terry D. Foutz,et al. Partial Phosphorylation of the N-Formyl Peptide Receptor Inhibits G Protein Association Independent of Arrestin Binding* , 2001, The Journal of Biological Chemistry.
[190] J. Thorner,et al. Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.
[191] P A Ward,et al. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. , 1984, The Journal of biological chemistry.
[192] J. Pin,et al. G Protein Activation by the Leukotriene B4 Receptor Dimer , 2008, Journal of Biological Chemistry.
[193] L. Sklar,et al. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions. , 1994, Molecular pharmacology.
[194] I. Nishimoto,et al. Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer's Disease-Relevant Insults , 2001, The Journal of Neuroscience.
[195] P. Henson,et al. The sequential release of granule constitutents from human neutrophils. , 1980, Journal of immunology.
[196] Ji Ming Wang,et al. Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.
[197] Jingsong Xu,et al. Divergent Signals and Cytoskeletal Assemblies Regulate Self-Organizing Polarity in Neutrophils , 2003, Cell.
[198] S. Hinuma,et al. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. , 2004, Biochemical and biophysical research communications.
[199] J. Woska,et al. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells , 1998, Cell and Tissue Research.
[200] Yeong‐Min Park,et al. The Synthetic Peptide Trp-Lys-Tyr-Met-Val-D-Met Inhibits Human Monocyte-Derived Dendritic Cell Maturation via Formyl Peptide Receptor and Formyl Peptide Receptor-Like 21 , 2005, The Journal of Immunology.
[201] E. Prossnitz,et al. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. , 1993, The Journal of biological chemistry.
[202] V. Basso,et al. The soluble D2D388-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion , 2004, Journal of Cell Science.
[203] F. Luscinskas,et al. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: Dissociation between lipid remodeling and adhesion , 1990, Journal of cellular physiology.
[204] E. Dratz,et al. Characterization of complex formation between Gi2 and octyl glucoside solubilized neutrophil N-formyl peptide chemoattractant receptor by sedimentation velocity. , 1994, Biochimica et biophysica acta.
[205] J. Kwak,et al. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. , 2005, Biochemical and biophysical research communications.
[206] J. Gallin,et al. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe. , 1981, Journal of immunology.
[207] Philip M. Murphy,et al. Molecular mimicry and the generation of host defense protein diversity , 1993, Cell.
[208] V. Ferrans,et al. β Amyloid peptide (Aβ42) is internalized via the G‐protein‐coupled receptor FPRL1 and forms fibrillar aggregates in macrophages1 , 2001 .
[209] M. Cassatella,et al. Activation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils , 1997 .
[210] G. Bokoch,et al. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. , 1991, Science.
[211] C. Dahlgren,et al. Tumour necrosis factor (TNF)‐α primes murine neutrophils when triggered via formyl peptide receptor‐related sequence 2, the murine orthologue of human formyl peptide receptor‐like 1, through a process involving the type I TNF receptor and subcellular granule mobilization , 2008, Immunology.
[212] A. Mantovani,et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. , 1992, Blood.
[213] R. Simmons,et al. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. , 1975, Journal of immunology.
[214] A. Jesaitis,et al. Identification of Putative Sites of Interaction between the Human Formyl Peptide Receptor and G Protein* , 1999, The Journal of Biological Chemistry.
[215] Algirdas J. Jesaitis,et al. Identification of a Ligand Binding Site in the Human Neutrophil Formyl Peptide Receptor Using a Site-specific Fluorescent Photoaffinity Label and Mass Spectrometry* , 1998, The Journal of Biological Chemistry.
[216] P. Murphy,et al. Impaired Antibacterial Host Defense in Mice Lacking the N-formylpeptide Receptor , 1999, The Journal of experimental medicine.
[217] D. Haviland,et al. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation , 1995, The Journal of experimental medicine.
[218] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[219] C. Fraser,et al. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.
[220] S. Marullo,et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor , 2002, Nature Medicine.
[221] M. Rodbell,et al. Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity. , 1977, The Journal of biological chemistry.
[222] E A Dratz,et al. The ligand binding site of the formyl peptide receptor maps in the transmembrane region. , 1997, Journal of immunology.
[223] Jennifer E. Golden,et al. Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. , 2006, Bioorganic & medicinal chemistry letters.
[224] D. McDermott,et al. Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1R , 2001, Genes and Immunity.
[225] H. Sengeløv,et al. Human neutrophil granules and secretory vesicles , 1993, European journal of haematology.
[226] L. Bjeldanes,et al. Lipoxin A4: a new class of ligand for the Ah receptor. , 1999, Biochemistry.
[227] J. Oppenheim,et al. Temporin A and Related Frog Antimicrobial Peptides Use Formyl Peptide Receptor-Like 1 as a Receptor to Chemoattract Phagocytes1 , 2004, The Journal of Immunology.
[228] M. Cassatella,et al. Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils. , 1997, Blood.
[229] C. Kozak,et al. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. , 1998, Genomics.
[230] T. Katada,et al. Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. , 1984, The Journal of biological chemistry.
[231] C. Serhan,et al. Induction of functional lipoxin A4 receptors in HL-60 cells. , 1993, Blood.
[232] E. Prossnitz,et al. Transmembrane signalling by the N-formyl peptide receptor in stably transfected fibroblasts. , 1991, Biochemical and biophysical research communications.
[233] R. Ulevitch,et al. Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. , 1996, Archives of biochemistry and biophysics.
[234] B. Bresnihan,et al. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. , 2004, Arthritis and rheumatism.
[235] J. Madara,et al. Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins. , 2002, Advances in experimental medicine and biology.
[236] G. Bokoch,et al. Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling. Mapping with receptor-derived peptides. , 1994, The Journal of biological chemistry.
[237] M. Yoder,et al. Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes. , 1979, The Journal of laboratory and clinical medicine.
[238] C. Serhan,et al. Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. , 1992, The Journal of biological chemistry.
[239] M. Camps,et al. Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits. , 1992, Nature.
[240] A. Jesaitis,et al. Reconstitution of recombinant N‐formyl chemotactic peptide receptor with G protein , 1993, Journal of leukocyte biology.
[241] M. Perretti,et al. Antiflammin-2 Activates the Human Formyl-Peptide Receptor Like 1 , 2006, TheScientificWorldJournal.
[242] I. Akritopoulou‐Zanze,et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.
[243] K. Hellstrand,et al. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. , 2001, The Journal of clinical investigation.
[244] U. Rescher,et al. Agonist-induced trafficking of the low-affinity formyl peptide receptor FPRL1 , 2004, Cellular and Molecular Life Sciences CMLS.
[245] C. Movitz,et al. Neutrophil NADPH‐oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors , 2005, Journal of leukocyte biology.
[246] R. Lefkowitz,et al. Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling , 2003 .
[247] W. Gong,et al. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. , 2000, Biochemical and biophysical research communications.
[248] C. Serhan,et al. Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis , 1999, The Journal of experimental medicine.
[249] C. Godson,et al. Lipoxins: update and impact of endogenous pro-resolution lipid mediators. , 2008, Reviews of physiology, biochemistry and pharmacology.
[250] J. Shabanowitz,et al. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. , 1996, Immunity.
[251] D. Cimino,et al. Regulation of N-Formyl Peptide Receptor Signaling and Trafficking by Individual Carboxyl-Terminal Serine and Threonine Residues1 , 2006, The Journal of Immunology.
[252] U. Rescher,et al. An Annexin 1 N-Terminal Peptide Activates Leukocytes by Triggering Different Members of the Formyl Peptide Receptor Family1 , 2004, The Journal of Immunology.
[253] M. Hekman,et al. Multisite contacts involved in coupling of the β-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein , 1991 .
[254] J. Benovic,et al. β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor , 1996, Nature.
[255] F. DeLeo,et al. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. , 1998, The Journal of clinical investigation.
[256] P. Sigler,et al. Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation. , 2001, Structure.
[257] M. Tardif,et al. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. , 1990, Biochemical and biophysical research communications.
[258] G. Rossi,et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. , 2005, Blood.
[259] J. Gauldie,et al. The acute phase response. , 1994, Immunology today.
[260] L A Sklar,et al. Analysis of ligand-receptor interactions with the fluorescence activated cell sorter. , 1982, Cytometry.
[261] R. Ye,et al. Erratum: Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1 (Molecular Pharmacology (2007) 72 (976-983)) , 2007 .
[262] P. Macmathuna,et al. Lipoxin A4 and Aspirin-Triggered 15-Epi-Lipoxin A4 Antagonize TNF-α-Stimulated Neutrophil-Enterocyte Interactions In Vitro and Attenuate TNF-α-Induced Chemokine Release and Colonocyte Apoptosis in Human Intestinal Mucosa Ex Vivo1 , 2001, The Journal of Immunology.
[263] R. Lefkowitz,et al. The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. , 1982, Biochemical and biophysical research communications.
[264] S. Whittemore,et al. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia , 1995, Journal of Neuroimmunology.
[265] B. Premack,et al. Proinflammatory Proteases Liberate a Discrete High-Affinity Functional FPRL1 (CCR12) Ligand from CCL2312 , 2007, The Journal of Immunology.
[266] F. Boulay,et al. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: An overview , 2007, Biochimie.
[267] G. Marone,et al. Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 21 , 2004, The Journal of Immunology.
[268] H. Harris. Role of chemotaxis in inflammation. , 1954, Physiological reviews.
[269] C. Garlanda,et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. , 2000, Science.
[270] D. Rotrosen,et al. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells. , 1987, Journal of immunology.
[271] C. Serhan,et al. Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. , 1993, Biochemistry.
[272] D. Sadlier,et al. Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. , 2005, The American journal of pathology.
[273] U. Francke,et al. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. , 1992, The Journal of biological chemistry.
[274] R. Ye,et al. The Immunosuppressant Cyclosporin A Antagonizes Human Formyl Peptide Receptor through Inhibition of Cognate Ligand Binding1 , 2006, The Journal of Immunology.
[275] Hugh R. Brady,et al. Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages1 , 2000, The Journal of Immunology.
[276] J. Cunningham,et al. N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells. , 1993, The Journal of biological chemistry.
[277] R. Adams,et al. Formyl peptide receptor chimeras define domains involved in ligand binding. , 1993, The Journal of biological chemistry.
[278] W. Gong,et al. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. , 1999, Journal of immunology.
[279] M. Yaffe,et al. The PX domains of p47phox and p40phox bind to lipid products of PI(3)K , 2001, Nature Cell Biology.
[280] R. Ye. Regulation of nuclear factor κB activation by G‐protein‐coupled receptors , 2001, Journal of leukocyte biology.
[281] O. Hazeki,et al. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production. , 1999, The Biochemical journal.
[282] J. Navarro,et al. Molecular cloning of the fMet-Leu-Phe receptor from neutrophils. , 1990, The Journal of biological chemistry.
[283] F. Yarovinsky,et al. Mouse Cathelin-Related Antimicrobial Peptide Chemoattracts Leukocytes Using Formyl Peptide Receptor-Like 1/Mouse Formyl Peptide Receptor-Like 2 as the Receptor and Acts as an Immune Adjuvant1 , 2005, The Journal of Immunology.
[284] H. Bourne,et al. Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[285] R. Ye,et al. Identification of Formyl Peptides from Listeria monocytogenes and Staphylococcus aureus as Potent Chemoattractants for Mouse Neutrophils1 , 2008, The Journal of Immunology.
[286] R. Snyderman,et al. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization. , 1993, The Journal of biological chemistry.
[287] P. Cuatrecasas,et al. Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils. , 1979, The Journal of biological chemistry.
[288] M. Thelen,et al. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[289] The formyl peptide chemoattractant receptor is encoded by a 2 kilobase messenger RNA , 1990, FEBS letters.
[290] Michael Kimelman,et al. Serum Amyloid A Binding to CLA-1 (CD36 and LIMPII Analogous-1) Mediates Serum Amyloid A Protein-induced Activation of ERK1/2 and p38 Mitogen-activated Protein Kinases* , 2005, Journal of Biological Chemistry.
[291] S. Steinberg,et al. Activated N-formyl peptide receptor and high-affinity IgE receptor occupy common domains for signaling and internalization. , 2007, Molecular biology of the cell.
[292] B. Seed,et al. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[293] J. Klein,et al. Akt Phosphorylates p47phox and Mediates Respiratory Burst Activity in Human Neutrophils1 , 2003, The Journal of Immunology.
[294] W. Nauseef. How human neutrophils kill and degrade microbes: an integrated view , 2007, Immunological reviews.
[295] B. Heit,et al. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients , 2002, The Journal of cell biology.
[296] Z. Li,et al. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. , 2000, Science.
[297] M. Dinauer,et al. A Critical Role of Protein Kinase Cδ Activation Loop Phosphorylation in Formyl-Methionyl-Leucyl-Phenylalanine-Induced Phosphorylation of p47phox and Rapid Activation of Nicotinamide Adenine Dinucleotide Phosphate Oxidase1 , 2007, The Journal of Immunology.
[298] J. Goyette,et al. Serum Amyloid A Induces Monocyte Tissue Factor1 , 2007, The Journal of Immunology.
[299] A. Karlsson,et al. Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-Phe. , 2004, Experimental cell research.
[300] A. Abo,et al. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1 , 1991, Nature.
[301] M. Teixeira,et al. The Required Role of Endogenously Produced Lipoxin A4 and Annexin-1 for the Production of IL-10 and Inflammatory Hyporesponsiveness in Mice1 , 2007, The Journal of Immunology.
[302] D. Williams,et al. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. , 1999, Immunity.
[303] W. Liles,et al. Glucocorticoids inhibit apoptosis of human neutrophils. , 1995, Blood.
[304] K. Jakobs,et al. Complementation of formyl peptide receptor-mediated signal transduction in Xenopus laevis oocytes. , 1992, The Biochemical journal.
[305] R. Ye,et al. Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice. , 2002, Gene.
[306] L. Kjeldsen,et al. Control of exocytosis in early neutrophil activation. , 1993, Journal of immunology.
[307] M. Tardif,et al. Isolation and characterization of a variant HL60 cell line defective in the activation of the NADPH oxidase by phorbol myristate acetate. , 1998, Journal of immunology.
[308] G. Paré,et al. Class IA Phosphatidylinositide 3-Kinases, rather than p110γ, Regulate Formyl-Methionyl-Leucyl-Phenylalanine-Stimulated Chemotaxis and Superoxide Production in Differentiated Neutrophil-Like PLB-985 Cells1 , 2006, The Journal of Immunology.
[309] C. Serhan,et al. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. , 1996, Journal of immunology.
[310] R. Ye,et al. Differential Roles of the NPXXY Motif in Formyl Peptide Receptor Signaling1 , 2001, The Journal of Immunology.
[311] R. Lefkowitz,et al. Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes. , 1983, The Journal of clinical investigation.
[312] M. Tardif,et al. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. , 1990, Biochemistry.
[313] A. Jesaitis,et al. The N-Formyl Peptide Receptor , 1999 .
[314] E. Prossnitz,et al. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications. , 1993, Journal of immunology.
[315] Dianqing Wu,et al. Gα16 Couples Chemoattractant Receptors to NF-κB Activation1 , 2001, The Journal of Immunology.
[316] A. Malik,et al. G alpha 16 couples chemoattractant receptors to NF-kappa B activation. , 2001, Journal of immunology.
[317] H. Miettinen,et al. Variable responses of formyl peptide receptor haplotypes toward bacterial peptides , 2008, Immunogenetics.
[318] C. Serhan,et al. Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation , 2000, The Journal of experimental medicine.
[319] M. Simon,et al. Purification from Sf9 cells and characterization of recombinant Gq alpha and G11 alpha. Activation of purified phospholipase C isozymes by G alpha subunits. , 1993, The Journal of biological chemistry.
[320] E. Leonard,et al. Staphylococcus aureus Tetrapeptide With High Chemotactic Potency and Efficacy for Human Leukocytes , 1989, Journal of leukocyte biology.
[321] H. Miettinen,et al. Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2. , 2008, Cellular signalling.
[322] Melvin I. Simon,et al. Different α1-Adrenergic Receptor Sequences Required for Activating Different Gα Subunits of Gq Class of G Proteins (*) , 1995, The Journal of Biological Chemistry.
[323] C. Serhan,et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[324] I. Williams,et al. Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. , 2003, American journal of physiology. Cell physiology.
[325] C. Serhan,et al. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor , 1994, The Journal of experimental medicine.
[326] A. Sharma,et al. Single nucleotide polymorphisms of the N-formyl peptide receptor in localized juvenile periodontitis. , 1999, Journal of periodontology.
[327] M. Perretti,et al. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. , 2001, The American journal of pathology.
[328] E. Leonard,et al. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[329] Paul Herzmark,et al. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils , 2002, Nature Cell Biology.
[330] E. Prossnitz,et al. Phosphorylation of the N-Formyl Peptide Receptor Is Required for Receptor Internalization but Not Chemotaxis* , 1997, The Journal of Biological Chemistry.
[331] P. Cuatrecasas,et al. Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils. , 1979, Science.
[332] J. Robotham,et al. The acute-phase response. , 1995, New horizons.
[333] A. Jesaitis,et al. Membrane‐cytoskeleton interactions and the regulation of chemotactic peptide‐induced activation of human granulocytes: The effects of dihydrocytochalasin B , 1985, Journal of cellular biochemistry.
[334] J. Benovic,et al. Phosphorylation of the N-Formyl Peptide Receptor Carboxyl Terminus by the G Protein-coupled Receptor Kinase, GRK2 (*) , 1995, The Journal of Biological Chemistry.
[335] P. Murphy,et al. The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor. , 2000, Biochemical and biophysical research communications.
[336] F. Boulay,et al. Human mitochondria‐derived N‐formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes‐derived peptides preferentially activate FPR , 2005, European journal of immunology.
[337] Philip M Murphy,et al. Formyl-peptide receptors revisited. , 2002, Trends in immunology.
[338] W. Gong,et al. Expression of functional formyl peptide receptors by human astrocytoma cell lines , 2000, Journal of Neuroimmunology.
[339] A. Mócsai,et al. Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. , 1999, Journal of immunology.
[340] P. Wilkinson. Synthetic peptide chemotactic factors for neutrophils: the range of active peptides, their efficacy and inhibitory activity, and susceptibility of the cellular response to enzymes and bacterial toxins. , 1979, Immunology.
[341] K. Jakobs,et al. Stimulation of phospholipase C by guanine‐nucleotide‐binding protein βγ subunits , 1992 .
[342] C. Dahlgren,et al. The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2* , 2001, The Journal of Biological Chemistry.
[343] C. Haslett,et al. Priming induces functional coupling of N‐formyl‐methionyl‐leucyl‐phenylalanine receptors in equine neutrophils , 1998, Journal of leukocyte biology.
[344] B. Dolmatch,et al. Formyl peptide chemotactic receptor. Evidence for an active proteolytic fragment. , 1983, The Journal of biological chemistry.
[345] J. Wallace,et al. Aspirin-Triggered, Cyclooxygenase-2–Dependent Lipoxin Synthesis Modulates Vascular Tone , 2004, Circulation.
[346] M. P. Fletcher,et al. Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine. , 1983, Blood.
[347] E. Lycke,et al. Altered kinetic properties of sialyl and galactosyl transferases associated with herpes simplex virus infection of GMK and BHK cells. , 1980, The Journal of general virology.
[348] G. Armitage,et al. Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis. , 1991, The Journal of clinical investigation.
[349] K. Wenzel-Seifert,et al. High Constitutive Activity of the Human Formyl Peptide Receptor* , 1998, The Journal of Biological Chemistry.
[350] Sachin Agarwal,et al. Altered free cytosolic calcium changes and neutrophil chemotaxis in patients with juvenile periodontitis. , 1989, Journal of periodontal research.
[351] Hui-yu Liu,et al. Quantitative Analysis of Formyl Peptide Receptor Coupling to Giα1, Giα2, and Giα3 * , 1999, The Journal of Biological Chemistry.
[352] A. Jesaitis,et al. Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: formation of high-affinity ligand- receptor complexes in transient association with cytoskeleton , 1984, The Journal of cell biology.
[353] K. Jakobs,et al. Stimulation of phospholipase C by guanine-nucleotide-binding protein beta gamma subunits. , 1992, European journal of biochemistry.
[354] T. Takano,et al. Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors , 1997, The Journal of experimental medicine.
[355] A. Chambers,et al. Expression in Xenopus oocytes. , 1990, Current opinion in biotechnology.
[356] A. Karlsson,et al. Lipopolysaccharide-Induced Gelatinase Granule Mobilization Primes Neutrophils for Activation by Galectin-3 and Formylmethionyl-Leu-Phe , 2001, Infection and Immunity.
[357] N. Petasis,et al. Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases. , 2002, The American journal of pathology.
[358] P. Murphy,et al. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. , 1993, The Journal of biological chemistry.
[359] R. Traber,et al. Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor. , 2002, Journal of medicinal chemistry.
[360] J. Benovic,et al. The ins and outs of G protein-coupled receptor trafficking. , 2003, Trends in biochemical sciences.
[361] H. P. Monteiro,et al. Is serum amyloid A an endogenous TLR4 agonist? , 2008, Journal of leukocyte biology.
[362] G. Bokoch,et al. Regulation of ligand-receptor dynamics by guanine nucleotides. Real-time analysis of interconverting states for the neutrophil formyl peptide receptor. , 1987, The Journal of biological chemistry.
[363] R. D. Mellon,et al. Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants. , 2002, Biochemical pharmacology.
[364] S. Ryu,et al. Serum Amyloid A Binding to Formyl Peptide Receptor-Like 1 Induces Synovial Hyperplasia and Angiogenesis1 , 2006, The Journal of Immunology.
[365] J. Mills. Differential activation of polymorphisms of the formyl peptide receptor by formyl peptides , 2007, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[366] K. Okkenhaug,et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. , 2005, Blood.
[367] Zigmond Sh. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. , 1977 .
[368] V. Niggli,et al. The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils. , 1997, European journal of pharmacology.
[369] V. Gerke,et al. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. , 2000, Molecular cell.
[370] J. Kwak,et al. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. , 2003, Molecular pharmacology.
[371] P. Grieco,et al. Cross-talk between fMLP and Vitronectin Receptors Triggered by Urokinase Receptor-derived SRSRY Peptide* , 2005, Journal of Biological Chemistry.
[372] L A Sklar,et al. The dynamics of ligand-receptor interactions. Real-time analyses of association, dissociation, and internalization of an N-formyl peptide and its receptors on the human neutrophil. , 1984, The Journal of biological chemistry.
[373] T. MacVittie,et al. Migration of dog polymorphonuclear neutrophilic leukocytes to formylated peptides , 1990, Inflammation.
[374] M. Dinauer,et al. Reconstitution of Chemotactic Peptide-Induced Nicotinamide Adenine Dinucleotide Phosphate (Reduced) Oxidase Activation in Transgenic COS-phox Cells1 , 2004, The Journal of Immunology.
[375] M. Hekman,et al. Multisite contacts involved in coupling of the beta-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein. Structural and functional studies by beta-receptor-site-specific synthetic peptides. , 1991, European journal of biochemistry.
[376] A. Jesaitis,et al. 399 MUTATIONS OF F110 AND C126 OF THE FORMYL PEPTIDE RECEPTOR INTERFERE WITH G-PROTEIN COUPLING AND CHEMOTAXIS. , 2003, Journal of Investigative Medicine.
[377] R. Chiron,et al. LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[378] C. Brenner,et al. Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis. , 2002, Biochemistry.
[379] A. Day,et al. Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils. , 1982, Biochemistry.
[380] J. Johndrow,et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent , 2006, Nature Medicine.
[381] G. Marone,et al. Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2–20)1 , 2004, The Journal of Immunology.
[382] M. Caron,et al. β-Arrestin/AP-2 Interaction in G Protein-coupled Receptor Internalization , 2002, The Journal of Biological Chemistry.
[383] H. Carp. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils , 1982, The Journal of experimental medicine.
[384] M. Gougerot-Pocidalo,et al. TNF-alpha induces phosphorylation of p47(phox) in human neutrophils: partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF-alpha and granulocyte-macrophage colony-stimulating factor. , 2003, Journal of immunology.
[385] S. Zahler,et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.
[386] M. Simon,et al. G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[387] M. Caron,et al. Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. , 1987, Science.
[388] P. Chanez,et al. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[389] J. Varga,et al. Lipoxin A4 Inhibits IL-1β-Induced IL-6, IL-8, and Matrix Metalloproteinase-3 Production in Human Synovial Fibroblasts and Enhances Synthesis of Tissue Inhibitors of Metalloproteinases1 , 2000, The Journal of Immunology.
[390] R. Ye,et al. Identification of Novel Formyl Peptide Receptor-Like 1 Agonists That Induce Macrophage Tumor Necrosis Factor α Production , 2008, Molecular Pharmacology.
[391] E. Prossnitz,et al. Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach. , 1997, Biochemical and biophysical research communications.
[392] S. Su,et al. N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes. , 2000, Clinical immunology.
[393] L. Kjeldsen,et al. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. , 1994, The Biochemical journal.
[394] F. DeLeo,et al. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins , 1996, Journal of leukocyte biology.
[395] M. Simon,et al. Purification and characterization of recombinant G16 alpha from Sf9 cells: activation of purified phospholipase C isozymes by G-protein alpha subunits. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[396] K. Klotz,et al. A carboxyl‐terminal tail peptide of neutrophil chemotactic receptor disrupts its physical complex with G protein , 1993, Journal of leukocyte biology.
[397] W. Gong,et al. Potential role of the formyl peptide receptor‐like 1 (FPRL1) in inflammatory aspects of Alzheimer’s disease , 2002, Journal of leukocyte biology.
[398] S. Kunapuli,et al. Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils. , 2003, International immunopharmacology.
[399] J. V. van Strijp,et al. A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 11 , 2006, The Journal of Immunology.
[400] Eric R. Prossnitz,et al. N-Formyl Peptide Receptor Phosphorylation Domains Differentially Regulate Arrestin and Agonist Affinity* , 2003, The Journal of Biological Chemistry.
[401] C. Serhan,et al. Aspirin-Triggered Lipoxins Override the Apoptosis-Delaying Action of Serum Amyloid A in Human Neutrophils: A Novel Mechanism for Resolution of Inflammation1 , 2007, The Journal of Immunology.
[402] J. A. Radding,et al. Further studies on the structural requirements for synthetic peptide chemoattractants. , 1980, Biochemistry.
[403] S. Marullo,et al. A novel calcium‐dependent proapoptotic effect of annexin 1 on human neutrophils , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[404] R. Ye,et al. Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A1 , 2008, The Journal of Immunology.
[405] C. Serhan,et al. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction , 1996, The Journal of experimental medicine.
[406] C. Serhan. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[407] M. Gougerot-Pocidalo,et al. TNF-α Induces Phosphorylation of p47phox in Human Neutrophils: Partial Phosphorylation of p47phox Is a Common Event of Priming of Human Neutrophils by TNF-α and Granulocyte-Macrophage Colony-Stimulating Factor 1 , 2003, The Journal of Immunology.
[408] R. Ye,et al. A Novel Nonpeptide Ligand for Formyl Peptide Receptor-Like 1 , 2004, Molecular Pharmacology.
[409] Charles N. Serhan,et al. Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6 , 2008, The Journal of experimental medicine.
[410] M. Baggiolini,et al. Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[411] J. Oppenheim,et al. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. , 1992, Immunology today.
[412] Tudor I. Oprea,et al. Integration of Virtual Screening with High-Throughput Flow Cytometry to Identify Novel Small Molecule Formylpeptide Receptor Antagonistss⃞ , 2005, Molecular Pharmacology.
[413] A. Jesaitis,et al. A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis. , 2000, The Biochemical journal.
[414] J. P. Bennett. The bacterial factors which stimulate neutrophils may be derived from procaryote signal peptides , 1980, FEBS letters.
[415] Xiaoping Du,et al. Regulation of Leukocyte Degranulation by cGMP-Dependent Protein Kinase and Phosphoinositide 3-Kinase: Potential Roles in Phosphorylation of Target Membrane SNARE Complex Proteins in Rat Mast Cells1 , 2007, The Journal of Immunology.
[416] G. Bridger,et al. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor. , 1996, Journal of medicinal chemistry.
[417] D. Cimino,et al. N-Formyl Peptide Receptors Internalize but Do Not Recycle in the Absence of Arrestins* , 2003, Journal of Biological Chemistry.
[418] S. Zigmond,et al. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils , 1976, The Journal of experimental medicine.
[419] S. Wahl,et al. N-formylmethionyl peptides as chemoattractants for leucocytes. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[420] M. Perretti,et al. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. , 2003, Blood.
[421] A. Sher,et al. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity , 2002, Nature Immunology.
[422] W. Gong,et al. A Seven-transmembrane, G Protein–coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells , 1999, The Journal of experimental medicine.
[423] W. Gong,et al. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. , 1999, Blood.
[424] M. Dinauer,et al. Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system. , 2002, Blood.